A critical advance in cancer study is arising with the use of nanobodies to re-engage mutated p53. This crucial malignant protector protein is frequently inactivated in various types of cancer, causing uncontrolled https://kingbookmark.com/story22009975/vhh-fragments-revive-the-p53-protein-the-potential-hope-for-malignant-management